Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lack of Tumors in Infants With Perinatal HIV-1 Exposure and Fetal/Neonatal Exposure to Zidovudine

1 Apr 1999

Abstract excerpt

Zidovudine (ZDV) therapy during pregnancy and to the neonate reduced perinatal HIV transmission by nearly 70% in Pediatric AIDS Clinical Trials Group (PACTG) protocol 076. ZDV has been reported as positive in several in vitro carcinogenicity screening tests. We evaluated the short-term risk for tumors in 727 children with known ZDV exposure enrolled into the PACTG 076/219 and the Women and Infants Transmission...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HIV/AIDS drug development and treatment
Share to HIV/AIDS Research and Interventions
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 10225228
DOI: 10.1097/00042560-199904150-00008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lack of Tumors in Infants With Perinatal HIV-1 Exposure and Fetal/Neonatal Exposure to ZidovudinePMID 10225228Read ↗

Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survival.Semantic proximity Read ↗

A Trigger-based Design for Evaluating the Safety of In Utero Antiretroviral Exposure in Uninfected Children of Human Immunodeficiency Virus-Infected MothersSemantic proximity Read ↗

Dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels.Semantic proximity Read ↗

HIV-1 Integrase Strand Transfer Inhibitors and NeurodevelopmentSemantic proximity Read ↗

Long-Term Mitochondrial Toxicity in HIV-Uninfected Infants Born to HIV-Infected MothersSemantic proximity Read ↗

Mutagenicity of zidovudine, lamivudine, and abacavir following in vitro exposure of human lymphoblastoid cells or in utero exposure of CD-1 mice to single agents or drug combinations.Semantic proximity Read ↗

The effects of zidovudine in the subset of infants infected with human immunodeficiency virus type-1 (Pediatric AIDS Clinical Trials Group Protocol 076).Semantic proximity Read ↗

Cancer in children and young adults born after assisted reproductive technology: a Nordic cohort study from the Committee of Nordic ART and Safety (CoNARTaS)Semantic proximity Read ↗

Perinatal genotoxicity and carcinogenicity of anti-retroviral nucleoside analog drugsSemantic proximity Read ↗

Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defectsSemantic proximity Read ↗

Transplacental Effects of 3'-Azido-2',3'-Dideoxythymidine (AZT): Tumorigenicity in Mice and Genotoxicity in Mice and MonkeysSemantic proximity Read ↗

Development of zidovudine-resistant HIV genotypes following postnatal prophylaxis in a perinatally infected infant.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.